Krsnaa Diagnostics announced that the Board of Directors of the Company at its meeting held on 27 May 2023, inter alia, have recommended the final dividend of Rs 2.75 per equity Share (i.e. 55%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Net profit of Krsnaa Diagnostics rose 5.46% to Rs 18.92 crore in the quarter ended March 2023 as against Rs 17.94 crore during the previous quarter ended March 2022. Sales rose 23.08% to Rs 133.23 crore in the quarter ended March 2023 as against Rs 108.25 crore during the previous quarter ended March 2022.

For the full year,net profit declined 9.18% to Rs 62.11 crore in the year ended March 2023 as against Rs 68.39 crore during the previous year ended March 2022. Sales rose 6.95% to Rs 487.12 crore in the year ended March 2023 as against Rs 455.45 crore during the previous year ended March 2022.

Powered by Capital Market - Live News

Net profit of Krsnaa Diagnostics declined 38.90% to Rs 11.81 crore in the quarter ended March 2023 as against Rs 19.33 crore during the previous quarter ended March 2022. Sales rose 7.44% to Rs 115.86 crore in the quarter ended March 2023 as against Rs 107.84 crore during the previous quarter ended March 2022.

For the full year,net profit declined 10.17% to Rs 63.51 crore in the year ended March 2023 as against Rs 70.70 crore during the previous year ended March 2022. Sales rose 2.02% to Rs 464.08 crore in the year ended March 2023 as against Rs 454.89 crore during the previous year ended March 2022.

Powered by Capital Market - Live News

Krsnaa Diagnostics will hold a meeting of the Board of Directors of the Company on 27 May 2023.

Powered by Capital Market - Live News